Doxazosin Tablet
Product Images NDC 71610-153
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71610-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Bottle Label 8 mg (71610 0160 16)
This is a bottle of Doxazosin medication containing 8mg tablets of the drug. There are 6000 tablets in the bottle. The medication is prescribed by a licensed physician or medical professional to treat hypertension or benign prostatic hyperplasia (BPH). The NOC# is provided for identification purposes. The rest of the text is not-available as it appears to be garbled or distorted.*
Aphena Pharma Solutions (TN)
Doxazosin-structure.jpg (Doxazosin Structure)
Figure1.jpg (Figure1)
Table3.jpg (Table3)
The text appears to be a summary of effectiveness data from placebo-controlled trials for doxazosin, a medication commonly used to treat symptoms related to an enlarged prostate gland in men (BPH). The data includes measurements of maximum flow rate and symptom scores before and after taking the medication. The text also includes study parameters, such as titration to a maximum or fixed dose and time since dose, as well as statistical comparisons to placebo. No additional information is available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.